Status:
COMPLETED
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
Lead Sponsor:
Zero Helicobacter IGAN Network
Collaborating Sponsors:
Oita University
Japan International Cooperation Agency
Conditions:
H.Pylori
Gastric Cancer
Eligibility:
All Genders
12-80 years
Phase:
NA
Brief Summary
Background: Helicobacter pylori is a major risk factor for gastric cancer, yet in many developing countries, including Bhutan where gastric cancer incidence is high, access to screening and eradicatio...
Detailed Description
The investigators enrolled permanent residents aged ≥12 years living in communities within the catchment area of Dawakha BHU II, Paro District, Bhutan, between December 2019 and March 2023. The object...
Eligibility Criteria
Inclusion
- • Both male and female age 12 years and above in the selected communities for H. pylori infection screening
- Both male and female age 18 years and above in the selected communities for H. pylori infection screening, eradication and endoscopy.
- Permanent residence of the communities
Exclusion
- Exclusion criteria for screening
- Individuals not consenting Exclusion criteria for eradication and endoscopy
- Pre-existing medical conditions where triple therapy or endoscopy is not recommended (mainly pregnant women, renal diseases, history of breathing difficulty)
Key Trial Info
Start Date :
December 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2023
Estimated Enrollment :
1043 Patients enrolled
Trial Details
Trial ID
NCT07211880
Start Date
December 5 2019
End Date
March 21 2023
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Khesar Gyalpo University of Medical Sciences of Bhutan
Thimphu, Thimphu District, Bhutan